Kazia Therapeutics【KZIA】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

1.415

買値

1.39

売値

1.55

出来高

36,789

1.39 日の範囲 1.52

0.00 52 週間の範囲 0.00

時価総額

4.71M

前日終値

1.46

始値

1.50

時刻

1.546

最終取引時間

財務取引量

US$ 54,037

VWAP

1.4688

平均取引量 (3 か月)

発行済株式数

3,328,508

配当利回り

PER

-0.01

1 株当たり利益 (EPS)

-8.21

歳入

2.31M

純利益

-27.32M

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others.

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.kaziatherapeutics.com

本社

Sydney, New South Wales, Aus

設立

Kazia Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker KZIA. The last closing price for Kazia Therapeutics was US$1.46. Over the last year, Kazia Therapeutics shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Kazia Therapeutics currently has 3,328,508 shares in issue. The market capitalisation of Kazia Therapeutics is US$4.86 million. Kazia Therapeutics has a price to earnings ratio (PE ratio) of -0.01.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

KZIA - Frequently Asked Questions (FAQ)

What is the current Kazia Therapeutics share price?

The current share price of Kazia Therapeutics is US$ 1.415

How many Kazia Therapeutics shares are in issue?

Kazia Therapeutics has 3,328,508 shares in issue

What is the market cap of Kazia Therapeutics?

The market capitalisation of Kazia Therapeutics is USD 4.86M

What is the 1 year trading range for Kazia Therapeutics share price?

Kazia Therapeutics has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Kazia Therapeutics?

The price to earnings ratio of Kazia Therapeutics is -0.01

What is the cash to sales ratio of Kazia Therapeutics?

The cash to sales ratio of Kazia Therapeutics is 0.12

What is the reporting currency for Kazia Therapeutics?

Kazia Therapeutics reports financial results in AUD

What is the latest annual turnover for Kazia Therapeutics?

The latest annual turnover of Kazia Therapeutics is AUD 2.31M

What is the latest annual profit for Kazia Therapeutics?

The latest annual profit of Kazia Therapeutics is AUD -27.32M

What is the registered address of Kazia Therapeutics?

The registered address for Kazia Therapeutics is THREE INTERNATIONAL TOWERS, LEVEL 24, 300 BARANGAROO TOWERS, SYDNEY, NEW SOUTH WALES, 2000

What is the Kazia Therapeutics website address?

The website address for Kazia Therapeutics is www.kaziatherapeutics.com

Which industry sector does Kazia Therapeutics operate in?

Kazia Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
BTCTBTC Digital Ltd	US$ 8.2697 (73.73%)	61.45M
BDMDBaird Medical Investment Holdings Ltd	US$ 8.80 (62.36%)	18.63M
CRKNCrown Electrokinetics Corporation	US$ 0.1235 (54.96%)	764.86M
NUKKNukkleus Inc	US$ 29.97 (45.98%)	19.09M
GSITGSI Technology	US$ 3.97 (44.36%)	87.7M
DOGZDogness International Corporation	US$ 18.23 (-58.77%)	740.45k
ORKTOrangeKloud Technology Inc	US$ 3.02 (-24.88%)	21.08M
PMAXPowell Max Ltd	US$ 0.6364 (-23.31%)	4.17M
LGCBLinkage Global Inc	US$ 0.2876 (-22.27%)	890.66k
YYAIConnexa Sports Technologies Inc	US$ 0.8299 (-20.20%)	602.48k
CRKNCrown Electrokinetics Corporation	US$ 0.1235 (54.96%)	764.86M
GCTKGlucoTrack Inc	US$ 0.0852 (15.45%)	465.22M
RIMEAlgorhythm Holdings Inc	US$ 0.0406 (-4.02%)	387.23M
TGLTreasure Global Inc	US$ 0.2459 (14.75%)	267.1M
NVDANVIDIA Corporation	US$ 137.71 (3.10%)	201.4M